Improve clinical care with AI
Improve clinical care with AI
Digitise and analyze all your clinical documentation
Proven Results. Scientifically Validated AI.
Proven Results. Scientifically Validated AI.
Proven Results. Scientifically Validated AI.
Our AI modules have been independently validated for safety and impact.
100%
Hallucination-free note generation
9.1/10
Meaningfulness assessed by independent clinicians
78%
Reduction in documentation time
Reduction in documentation time per doctor
Learn more
AI That Adapts to Every Clinical Setting
AI That Adapts to Every Clinical Setting
AI That Adapts to Every Clinical Setting
Our modular AI modules scale across diverse clinical workflows.
Our modular AI modules scale across diverse clinical workflows.
Note -1
Note -1
File -1
File -1
File -2
File -2
Note -2
Note -2
DISCHARGE SUMMARY
DISCHARGE SUMMARY
Diagnosis
Diagnosis
Primary Refractory DLBC (Diffuse Large B-Cell Lymphoma)
Primary Refractory DLBC (Diffuse Large B-Cell Lymphoma)
Reason for Admission
Reason for Admission
Re-apheresis + C1D15 Glofitamab
Re-apheresis + C1D15 Glofitamab
Age/Sex:
Age/Sex:
17-year-old Male
17-year-old Male
Comorbidities
Comorbidities
Diabetes Mellitus (Diabetic), Hypertension (HTN)
Diabetes Mellitus (Diabetic), Hypertension (HTN)
Family History (F/H):
Family History (F/H):
Sister had breast carcinoma
Sister had breast carcinoma
Automate Discharge Summaries
Automate Discharge Summaries
Automate Discharge Summaries
Generate comprehensive, accurate discharge summaries in seconds - seamlessly pulling patient details at the click of a button.
Generate comprehensive, accurate discharge summaries in seconds - seamlessly pulling patient details at the click of a button.
Generate comprehensive, accurate discharge summaries in seconds - seamlessly pulling patient details at the click of a button.
Fast-track Clinical Trials
Fast-track Clinical Trials
Capture case record data automatically, refer to protocol guidelines, and reduce compliance errors with real-time alerts
Capture case record data automatically, refer to protocol guidelines, and reduce compliance errors with real-time alerts
Capture case record data automatically, refer to protocol guidelines, and reduce compliance errors with real-time alerts
Transcript
APML Low Risk under evaluation
Started on ATRA (10mg) 4-0-3 since 15.4.25 - 18.4.25 (wef 20.1.25 in TMH)
ATO wef 19.4.25
Diagnostic samples sent today
Currently
No bleeding manifestations
c/o blurring of vision
Afebrile
VITALS
T 98F
PR 80/min
BP 110/70
sPO2 99% RA
RR 20/min
CVS: S1S2+ No murmurs
RS: Clear
PA: NAD
Labs (E)
Hb 12.6
Plt 60
TC 7.88
ANC 6.33
M 2.3
Na 137
K 3.45
Ca 9.47
P 3.72
Mg 1.81
Fibrinogen 144
PICC inserted today
Check Cxray done
Position verified
Baseline weight 51 kg
Weight today 50 kg
ECG QTc 421ms
NCCT thorax NAD
PLAN
1. Inj ATO 8mg IV D3
2. C ATRA 10mg 2-0-2 D2(D7 total)
3. T Sevelamer 400 mg TDS
4. 5U Cryo TDS
5. 1 SDP BD -HOLD
6. T Protrate 10 mg TDS
7. C Hydrea 1000 mg 1-1-1
Tumour Board Treatment plan
Patient Details
Parameter
Value
Age
48
Sex
Male
Date of Presentation
October 20, 2025
Extracted Text
Patient is a retired veteran presenting with a chief complaint of numbness in his left leg, from the knee down to the foot, for the past 3 days. Initially, he experienced a tingling sensation, which progressed to complete numbness. The numbness is affecting his daily activities, particularly walking, and he is concerned about falling. He reports no pain or weakness in the leg
Patient’s past medical history includes diabetes, hypertension, and sinusitis. He is taking metformin, lisinopril, and fluticasone as prescribed. He has noticed an increase in his blood sugar levels recently and had a bad episode of sinusitis…
Afebrile
Additional information
Based on the patient’s symptoms and physical examination, diabetic neuropathy is suspected as a complication of his diabetes. Elevated blood pressure and …
Transcript
APML Low Risk under evaluation
Started on ATRA (10mg) 4-0-3 since 15.4.25 - 18.4.25 (wef 20.1.25 in TMH)
ATO wef 19.4.25
Diagnostic samples sent today
Currently
No bleeding manifestations
c/o blurring of vision
Afebrile
VITALS
T 98F
PR 80/min
BP 110/70
sPO2 99% RA
RR 20/min
CVS: S1S2+ No murmurs
RS: Clear
PA: NAD
Labs (E)
Hb 12.6
Plt 60
TC 7.88
ANC 6.33
M 2.3
Na 137
K 3.45
Ca 9.47
P 3.72
Mg 1.81
Fibrinogen 144
PICC inserted today
Check Cxray done
Position verified
Baseline weight 51 kg
Weight today 50 kg
ECG QTc 421ms
NCCT thorax NAD
PLAN
1. Inj ATO 8mg IV D3
2. C ATRA 10mg 2-0-2 D2(D7 total)
3. T Sevelamer 400 mg TDS
4. 5U Cryo TDS
5. 1 SDP BD -HOLD
6. T Protrate 10 mg TDS
7. C Hydrea 1000 mg 1-1-1
Tumour Board Treatment plan
Patient Details
Parameter
Value
Age
48
Sex
Male
Date of Presentation
October 20, 2025
Extracted Text
Patient is a retired veteran presenting with a chief complaint of numbness in his left leg, from the knee down to the foot, for the past 3 days. Initially, he experienced a tingling sensation, which progressed to complete numbness. The numbness is affecting his daily activities, particularly walking, and he is concerned about falling. He reports no pain or weakness in the leg
Patient’s past medical history includes diabetes, hypertension, and sinusitis. He is taking metformin, lisinopril, and fluticasone as prescribed. He has noticed an increase in his blood sugar levels recently and had a bad episode of sinusitis…
Afebrile
Additional information
Based on the patient’s symptoms and physical examination, diabetic neuropathy is suspected as a complication of his diabetes. Elevated blood pressure and …
Transcript
APML Low Risk under evaluation
Started on ATRA (10mg) 4-0-3 since 15.4.25 - 18.4.25 (wef 20.1.25 in TMH)
ATO wef 19.4.25
Diagnostic samples sent today
Currently
No bleeding manifestations
c/o blurring of vision
Afebrile
VITALS
T 98F
PR 80/min
BP 110/70
sPO2 99% RA
RR 20/min
CVS: S1S2+ No murmurs
RS: Clear
PA: NAD
Labs (E)
Hb 12.6
Plt 60
TC 7.88
ANC 6.33
M 2.3
Na 137
K 3.45
Ca 9.47
P 3.72
Mg 1.81
Fibrinogen 144
PICC inserted today
Check Cxray done
Position verified
Baseline weight 51 kg
Weight today 50 kg
ECG QTc 421ms
NCCT thorax NAD
PLAN
1. Inj ATO 8mg IV D3
2. C ATRA 10mg 2-0-2 D2(D7 total)
3. T Sevelamer 400 mg TDS
4. 5U Cryo TDS
5. 1 SDP BD -HOLD
6. T Protrate 10 mg TDS
7. C Hydrea 1000 mg 1-1-1
Tumour Board Treatment plan
Patient Details
Parameter
Value
Age
48
Sex
Male
Date of Presentation
October 20, 2025
Extracted Text
Patient is a retired veteran presenting with a chief complaint of numbness in his left leg, from the knee down to the foot, for the past 3 days. Initially, he experienced a tingling sensation, which progressed to complete numbness. The numbness is affecting his daily activities, particularly walking, and he is concerned about falling. He reports no pain or weakness in the leg
Patient’s past medical history includes diabetes, hypertension, and sinusitis. He is taking metformin, lisinopril, and fluticasone as prescribed. He has noticed an increase in his blood sugar levels recently and had a bad episode of sinusitis…
Afebrile
Additional information
Based on the patient’s symptoms and physical examination, diabetic neuropathy is suspected as a complication of his diabetes. Elevated blood pressure and …
Transcript
Transcript
History of Presenting Illness
Sharp, stabbing pain in lower back. Difficulty sitting for extended periods. No injury or physical activity that could have caused the
History of Presenting Illness
Sharp, stabbing pain in lower back. Difficulty sitting for extended periods. No injury or physical activity that could have caused the
Clinical Notes
Clinical Notes
Location
Location
Lower back.
Lower back.
Intensity
Intensity
7/10 on a standardized pain scale (0 = no pain, 10 = worst possible pain)
7/10 on a standardized pain scale (0 = no pain, 10 = worst possible pain)
Characteristics
Characteristics
Sharp, stabbing pain.
Sharp, stabbing pain.
Impact
Impact
Difficulty sitting for extended periods.
Difficulty sitting for extended periods.
Onset and Cause
Onset and Cause
No known injury or physical activity contributing to the pain.
No known injury or physical activity contributing to the pain.
Dr. Jane Foster
Dr. Jane Foster
Use a standardized pain scale and document location, intensity, and characteristics.
Use a standardized pain scale and document location, intensity, and characteristics.
Digitise OPD Consultations
Digitise OPD Consultations
Digitise OPD Consultations
Record outpatient consultations hands-free and generate structured notes using templates tailored to your specialty and workflow.
Record outpatient consultations hands-free and generate structured notes using templates tailored to your specialty and workflow.
Record outpatient consultations hands-free and generate structured notes using templates tailored to your specialty and workflow.
Automate Health Registry Updates
Automate Health Registry Updates
Automate Health Registry Updates
Streamline registry management by automatically extracting and updating longitudinal patient data across multiple file types
Streamline registry management by automatically extracting and updating longitudinal patient data across multiple file types
Streamline registry management by automatically extracting and updating longitudinal patient data across multiple file types
What are the most common primary diagnosis sites and histology types?
Most common primary diagnosis sites and histology types
Most common primary diagnosis sites and histology types
Primary Diagnosis
Primary Diagnosis
Oral Cavity
Oral Cavity
Lung
Lung
Histology Type
Histology Type
Squamous Cell Carcinoma
Squamous Cell Carcinoma
Adenocarcinoma
Adenocarcinoma
Number of Patients
Number of Patients
145
145
98
98
Foster AI is going through patient files to find the right information
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Pathology
Pathology
Report
Report
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Progress
Progress
Report
Report
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Oncology
Oncology
Intake Form
Intake Form
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Radiology
Radiology
Report(PDF)
Report(PDF)
Biopsy
Biopsy
Results
Results
Processing 2,431/2431 documents..
Extracting histology terms... Normalizing diagnosis categories
Processing 2,431/2431 documents..
Extracting histology terms... Normalizing diagnosis categories
Analyzing Medical Data
I'm scanning through patient files to uncover recurring diagnosis and histology patterns.
Summary Stats
Total Patients Analyzed: 243
Total Patients Analyzed: 243
Total Diagnosis Types Identified: 18
Total Diagnosis Types Identified: 18
Top Histology: Squamous Cell Carcinoma (145 cases)
Top Histology: Squamous Cell Carcinoma (145 cases)
Average File Count per Patient: 12
Average File Count per Patient: 12
Your Data is Secure
Your Data is Secure
Your Data is Secure
We prioritize the highest standards of data protection and privacy for healthcare organizations
Foster never uses your patient data for model training.
All confidential information remains strictly private and access-controlled.
End-to-end encryption safeguards your data both in transit and at rest.
